|
[1]
|
Duong, T.A., Valeyrie-Allanore, L., Wolkenstein, P. and Chosidow, O. (2017) Severe Cutaneous Adverse Reactions to Drugs. The Lancet, 390, 1996-2011. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Rahib, L., Smith, B.D., Aizenberg, R., Rosenzweig, A.B., Fleshman, J.M. and Matrisian, L.M. (2014) Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States. Cancer Research, 74, 2913-2921. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Lima, A.L., Illing, T., Schliemann, S. and Elsner, P. (2017) Cutaneous Manifestations of Diabetes Mellitus: A Review. American Journal of Clinical Dermatology, 18, 541-553. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Kim, J., Yoon, N.Y., Kim, D.H., Jung, M., Jun, M., Park, H., et al. (2018) Impaired Permeability and Antimicrobial Barriers in Type 2 Diabetes Skin Are Linked to Increased Serum Levels of Advanced Glycation End‐Product. Experimental Dermatology, 27, 815-823. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Karadag, A.S., Ozlu, E. and Lavery, M.J. (2018) Cutaneous Manifestations of Diabetes Mellitus and the Metabolic Syndrome. Clinics in Dermatology, 36, 89-93. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
中华医学会, 中华医学会杂志社, 中华医学会皮肤性病学分会, 等. 药疹基层诊疗指南(2022年) [J]. 中华全科医师杂志, 2022, 21(9): 804-813.
|
|
[7]
|
Rafaqat, S., Khurshid, H., Hafeez, R., Arif, M., Zafar, A., Gilani, M., et al. (2024) Role of Interleukins in Pancreatic Cancer: A Literature Review. Journal of Gastrointestinal Cancer, 55, 1498-1510. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
杨凡萍, 陈圣安, 朱沁媛, 等. 1883例住院药疹患者致敏药物分析[J]. 中华临床免疫和变态反应杂志, 2017, 11(3): 232-240.
|
|
[9]
|
徐丹丹, 徐丹丹, 关明, 骆肖群. 药疹发病机制及预防诊断相关问题[J]. 中华预防医学杂志, 2021, 55(5): 574-582.
|
|
[10]
|
韩晶. 关于湿疹的研究综述[J]. 实用临床护理学电子杂志, 2018, 3(1): 191-192.
|
|
[11]
|
中华医学会皮肤性病学分会. 2025年重症药疹防治中国专家共识解读[EB/OL]. https://taodocs.com/p-1228586377.html, 2025-10-29.
|